Literature DB >> 10733998

The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK.

B K MacDonald1, O C Cockerell, J W Sander, S D Shorvon.   

Abstract

Over an 18-month period, all incident cases of neurological disorders were ascertained prospectively in an unselected urban population based in 13 general practices in the London area by a General Practice Linkage Scheme with the National Hospital for Neurology and Neurosurgery. In three of these practices, the lifetime prevalence of neurological disorders was also assessed. A population of 100 230 patients registered with participating general practices was followed prospectively for the onset of neurological disorders. Multiple methods of case finding were used to maintain accuracy. The age- and sex-adjusted incidence rates of neurological disorders were calculated. The lifetime prevalence of neurological disorders was surveyed in 27 658 of the patients. The age- and sex-adjusted incidence rates were calculated for major neurological conditions. [These are expressed as rates per 100 000 persons per annum, with 95% confidence intervals (CI) in parentheses]. The commonest of these were first cerebrovascular events, 205 (CI: 183, 230); shingles, 140 (CI: 104, 184); diabetic polyneuropathy, 54 (CI: 33, 83); compressive neuropathies, 49 (CI: 39, 61); epilepsy, 46 (CI: 36, 60); Parkinson's disease, 19 (CI: 12, 27); peripheral neuropathies, 15 (CI: 9, 23); CNS infections, 12 (CI: 5, 13); post-herpetic neuralgia, 11 (CI: 6, 17); and major neurological injuries, 10 (CI: 4, 11). Lifetime prevalence rates are also reported (expressed as rate per 1000 persons with 95% CI). The most prevalent conditions were: completed stroke, 9 (CI: 8, 11); transient ischaemic attacks, 5 (CI: 4, 6); active epilepsy, 4 (CI: 4, 5); congenital neurological deficit, 3 (CI: 3, 4); Parkinson's disease, 2 (CI: 1, 3); multiple sclerosis, 2 (CI: 2, 3); diabetic polyneuropathy, 2 (CI: 1, 3); compressive mononeuropathies, 2 (CI: 2, 3); and sub-arachnoid haemorrhage, 1 (CI: 0.8, 2). Overall, the onset of 625 neurological disorders was observed per 100 000 population annually. Six percent of the population had at some time had a neurological disorder. This is the first study of the incidence and lifetime prevalence of neurological disorders in recent times; we found that these disorders give rise to significant morbidity in the community.

Entities:  

Mesh:

Year:  2000        PMID: 10733998     DOI: 10.1093/brain/123.4.665

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  155 in total

1.  Ophthaproblem. Ocular myasthenia gravis.

Authors:  Stephanie Baxter; Sanjay Sharma
Journal:  Can Fam Physician       Date:  2002-11       Impact factor: 3.275

2.  No more neurophobia: welcome neurology in general practice.

Authors:  Leone Ridsdale
Journal:  Br J Gen Pract       Date:  2009-08       Impact factor: 5.386

3.  Neurologist care in Parkinson disease: a utilization, outcomes, and survival study.

Authors:  A W Willis; M Schootman; B A Evanoff; J S Perlmutter; B A Racette
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

4.  New diagnosis myasthenia gravis and preeclampsia in late pregnancy.

Authors:  John Ozcan; Ian Frank Balson; Alicia T Dennis
Journal:  BMJ Case Rep       Date:  2015-02-26

5.  A case of trigeminal neuralgia complicated by ipsilateral temporal arteritis.

Authors:  Yoko Kawaguchi; Masako Ebina; Tetsumi Sato; Yoh Ishiguro; Soroku Yagihashi; Kazuyoshi Hirota
Journal:  J Anesth       Date:  2010-02       Impact factor: 2.078

6.  Neurology training in the United Kingdom: a diagnostic analysis of over 5000 patients.

Authors:  Paul Maddison
Journal:  J Neurol       Date:  2005-03-04       Impact factor: 4.849

7.  Sociodemographic and clinical factors associated with depression in epilepsy.

Authors:  Alexander W Thompson; John W Miller; Wayne Katon; Naomi Chaytor; Paul Ciechanowski
Journal:  Epilepsy Behav       Date:  2009-02-20       Impact factor: 2.937

8.  Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study.

Authors:  K Pugdahl; A Fuglsang-Frederiksen; M de Carvalho; B Johnsen; P R W Fawcett; A Labarre-Vila; R Liguori; W A Nix; I S Schofield
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07       Impact factor: 10.154

Review 9.  Update on myasthenia gravis.

Authors:  B R Thanvi; T C N Lo
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

10.  Global campaign against epilepsy: assessment of a demonstration project in rural China.

Authors:  Wenzhi Wang; Jianzhong Wu; Xiuying Dai; Guangyu Ma; Bin Yang; Taiping Wang; Chenglin Yuan; Ding Ding; Zhen Hong; Patrick Kwan; Gail S Bell; Leonid L Prilipko; Hanneke M de Boer; Josemir W Sander
Journal:  Bull World Health Organ       Date:  2008-12       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.